Original Research
Published on 18 Feb 2026
ZFP161 promotes colorectal cancer progression by transcriptionally activating c-MYC
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1680561
- 302 views
Type at least 3 characters
3,144 articles
articles
Review
Published on 17 Feb 2026
The paradox of cellular senescence in prostate cancer: from tumor suppression to tumor promotion
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1743564
- 353 views
Review
Accepted on 16 Feb 2026
The dual regulatory role of METTL14-mediated m⁶A modification in tumorigenesis and its underlying mechanisms
in Molecular and Cellular Oncology
Frontiers in Oncology
Original Research
Published on 16 Feb 2026
Pilot study: predicting the interplay between FOXO1 and its downstream long non-coding RNAs in HCC
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1692980
- 255 views
Retraction
Accepted on 14 Feb 2026
Retraction: Pigment Epithelium-Derived Factor Promotes the Growth and Migration of Human Esophageal Squamous Cell Carcinoma
in Molecular and Cellular Oncology
Frontiers in Oncology
- 440 views
Original Research
Published on 13 Feb 2026
Dissecting the causal pathway linking HbA1c to oral cavity cancer via immune cell modulation: a bidirectional mendelian randomization analysis
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1768761
- 307 views
Review
Published on 11 Feb 2026
Molecular mechanisms and therapies for tumor inhibition through the arginine metabolism pathway
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1774392
- 441 views
Original Research
Published on 04 Feb 2026
Persistently high prevalence of HPV16 and rising prevalence of non-16/18 HR-HPV genotypes in cervical precancer and cancer in Latvia in 2016-2024 shape the severity of cervical disease
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1676334
- 528 views
Review
Published on 04 Feb 2026
Reframing tumor bed evaluation in non-small cell lung cancer: histopathological challenges and future directions in the era of neoadjuvant immunotherapy
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1716992
- 481 views
Original Research
Accepted on 30 Jan 2026
Molecular Remodeling of Cancer-Associated Fibroblasts in Breast Cancer Patients Receiving Anti–PD-1 Immunotherapy
in Molecular and Cellular Oncology
Frontiers in Oncology
- 335 views
Case Report
Published on 30 Jan 2026
Case Report: A case of Lynch syndrome-related glioblastoma with coexisting MSH2 splicing defect and MSH6 frameshift mutation
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1727445
- 830 views
Review
Accepted on 29 Jan 2026
AI-Powered Mapping of Tumor Immunity for Optimized mRNA Vaccine Engineering
in Molecular and Cellular Oncology
Frontiers in Oncology
- 499 views
Case Report
Published on 29 Jan 2026
Case report: Different outcomes of two cases of relapsed/refractory T cell acute lymphoblastic leukemia treated with anti-CD7 chimeric antigen receptor T cells bridging to allogeneic hematopoietic stem cell transplantation: from curative promise to fatal risk
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1766948
- 516 views
Original Research
Published on 28 Jan 2026
HPV11 targeting PPARA regulates the autophagy to inhibit the occurrence and development of nasal inverted papilloma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1743808
- 606 views
Review
Published on 27 Jan 2026
Role of lactylation modification in regulating lytic cell death
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1718636
- 556 views
Review
Published on 21 Jan 2026
Roles of E3 ubiquitin ligases and deubiquitinating enzymes in renal cell carcinoma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1628710
- 615 views
Original Research
Published on 20 Jan 2026
DSN1 drives breast cancer progression via cell cycle regulation: diagnostic and therapeutic implications
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1711214
- 751 views
Original Research
Published on 15 Jan 2026
Brexpiprazole inhibits EMT and migration of colorectal cancer cells by downregulating the SREBP1/SNAI1 signaling pathway
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1734678
- 722 views
Review
Published on 14 Jan 2026
The multifaceted regulatory roles of Nudix hydrolases in cancer and their therapeutic potential
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1743098
- 934 views
Review
Published on 13 Jan 2026
The pathogen’s playbook in cancer: from oncogenesis to progression
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1737423
- 960 views
Review
Published on 12 Jan 2026
Coactivator networks orchestrating noncanonical AR programs in enzalutamide-resistant CRPC
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1748527
- 1,073 views
Review
Published on 09 Jan 2026
Mechanisms of MTA3 in cancer and related diseases and its clinical applications
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1731799
- 838 views
Original Research
Published on 09 Jan 2026
High salt-induced osmotic stress differentially modulates hepatocellular and renal carcinoma cell proliferation
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1693591
- 1,181 views
Original Research
Published on 07 Jan 2026
TBX21 correlates with an immunosuppressive tumor microenvironment and Treg/Th17 imbalance in prostate cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1701148
- 855 views